3 Unstoppable Stocks to Buy in August
These growing companies are solid bets for the long term.
Mindfully Curated
These growing companies are solid bets for the long term.
With billions of these electronics in everyday use, they’ve become almost unavoidable at this point.
Several catalysts jolted EV stocks higher in July, but the market is already taking it back.
Most Dow stocks were winners last month, but not these.
Constructing a portfolio that is built to last requires investing in quality companies, purposeful allocation, and diversification.
Snap reported quarterly increases in revenue, daily active users, and average revenue per user.
Chipotle Mexican Grill shares were upended last month, but not for any good reason.
Intel is undertaking a massive business transition that is not going as well as hoped.
Investors are understandably curious about buying the dip in Nvidia stock.
The REIT continued taking steps to shore up its financial profile last month.
Investing in growth stocks has an excellent chance of increasing your wealth in the long run.
Demand for cloud migration services is surging thanks to booming interest in artificial intelligence.
Reports show that Nvidia may be having issues with its upcoming AI chips.
Kraft Heinz is changing its business, but there’s still a big portion that’s not desirable in the mix. Management is winning where it can.
Meta Platforms recently stated that it will continue to spend on AI infrastructure.
Amazon states that it has a strong partnership with Nvidia but will continue investing in its semiconductor solutions.
Intel stock dropped after reporting weak earnings, but is there something that could save this company?
Last week, the U.S. Food and Drug Administration (FDA) approved Guardant Health’s Shield™ blood test as a primary screening option for colorectal cancer (CRC) in adults aged 45 and older, marking a pivotal advance in the realm of cancer diagnostics. Ai…
Last week, the U.S. Food and Drug Administration (FDA) approved Guardant Health’s Shield™ blood test as a primary screening option for colorectal cancer (CRC) in adults aged 45 and older, marking a pivotal advance in the realm of cancer diagnostics. Ai…
Kinder Morgan’s investment thesis is noticeably improving in the age of AI.